The top 50 medical device companies in the world paid physicians and teaching hospitals $690.3 million last year in general payments, according to an analysis of Medical Design and Outsourcing‘s Big 100 and CMS Open Payments data. Medtech companies averaged $17.3 million in general payments to doctors last year, spending an average of 0.2% of […]
These medical device companies pay doctors the most money
The top medical device companies in the world made more than $542.6 million in general payments to physicians and hospitals in 2018, according to an analysis of Medical Design & Outsourcing‘s Big 100 and CMS Open Payments data. Zimmer Biomet topped the list with $109.4 million in general payments* to physicians and teaching hospitals in […]
Stent makers point to quality-of-life findings by massive federal study
The giant federal study that found the use of stents in stable heart-disease patients is no better than drugs to treat clogged arteries reached another, less-hyped conclusion. Manufacturers of stents for percutaneous coronary intervention (PCI) note that the Ischemia study also concluded that patients who undergo a stenting procedure have a better quality of life. They suffer […]
Boston Scientific issues safety notice for AngioJet Ultra consoles
Boston Scientific (NYSE:BSX) issued an urgent field safety notice to inform users of a correction to its AngioJet Ultra consoles that were shipped to customers without the required operator’s manual. The company said the consoles meet design specifications and are expected to perform as intended, as Boston Scientific determined that the correct use of the […]
Study: Stents no better than drugs for stable heart disease
This article has been updated with stock market results and comments from Medtronic. A major new study has concluded that the use of stents in stable heart disease patients is no better than drugs to treat clogged arteries. Results of the Ischemia study were released at the American Heart Association annual meeting in Philadelphia on Saturday. The […]
FDA aims to publicly report information on Watchman-related deaths
This article has been updated with comments from the American College of Cardiology. The FDA said Thursday that it plans to make public information on four patient deaths linked to Boston Scientific’s (NYSE:BSX) Watchman heart implant once it receives that information from the company. The agency said it has asked the sponsor of a Watchman […]
Report: FDA still hiding reports of patient deaths
This article has been updated with a response from Boston Scientific. The FDA is apparently allowing medtech companies to submit incomplete reports of device-related deaths, according to a new report by the StarTribune of Minneapolis. The news article says that the agency accepted one summary report covering four deaths related to Boston Scientific’s (NYSE:BSX) Watchman […]
BSX prices €900m in senior notes
Boston Scientific (NYSE:BSX) announced the pricing of a public offering worth nearly $1 billion in senior notes. The $993.9 million (€900 million) offering is the aggregate principal amount of Boston Scientific’s 0.625% notes due 2027 under the company’s shelf registration statement, according to a news release. Boston Scientific said it expects to receive the net proceeds […]
Coating snafu prompts recall of some Boston Scientific balloon catheters
Boston Scientific (NYSE:BSX) is voluntarily recalling certain dilation and extension catheters after finding that specific batches may have missed the hydrophilic coating step in the manufacturing process. That step is supposed to create a lubricious surface on the devices. Use of a catheter affected by the missed step could boost friction during delivery and withdrawal, delaying […]
Boston Scientific tops Q3 estimates, raises outlook
Boston Scientific (NYSE:BSX) beat the consensus estimate for both sales and earnings with its third-quarter results and raised its outlook on the rest of the year, sending share prices up today in pre-market trading. The Marlborough, Mass.-based medical device company posted profits of $126.0 million, or 9¢ per share, on sales of $2.71 billion for the […]
Boston Scientific launches $1B debt buyback
Boston Scientific (NYSE:BSX) said today that it plans to buy back up to $1 billion worth of its senior debt. The debt included in the tender offer is made up of $450 million in 4.125% notes due 2023; $1.0 billion in 4.0% notes due 2028; $750 million in 3.85% notes due 2025; and $500 million in […]
- 1
- 2
- 3
- …
- 142
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube